Closed · RFA-AI-14-008 · CFDA 93.242;93.855;93.856;93.865 · Discretionary

Sustained Release for Antiretroviral Treatment or Prevention (SRATP) of HIV Infection (UM1)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

Varies
Award range
Closed
Status
November 18, 2014
Close date
-
Expected awards

The verdict

Sustained Release for Antiretroviral Treatment or Prevention (SRATP) of HIV Infection (UM1) is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

Varies
award range
Closed
application status
93.242;93.855;93.856;93.865
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Sustained Release for Antiretroviral Treatmen… is closed (last close November 18, 2014). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed November 18, 2014

Posted May 14 Closes Nov 18

Instrument

Cooperative Agreement

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from single institutions and consortia of institutions to participate in the Sustained Release for Antiretroviral Treatment or Prevention (SRATP) of HIV Infection program. Applications may propose development of either treatment or prevention products containing antiretroviral agents delivered using sustained release delivery platforms (oral, injection, implant, transdermal or direct delivery to HIV target mucosa) with the objective of Phase 1 testing before the end of the award. Up to three independent Sustained Release Strategies (SRSs) may be proposed in an application. Each SRS must focus on the development of a separate product. The application must also include one of each of the following Sections: Program Operation Section (POS), Clinical Trial Section (CTS), IND-Enabling Section (IND-ES) and Administrative Coordination Section. Additional Scientific Projects and Scientific Support Sections that will facilitate the achievement of the SRATP sustained release objectives may be included. At least one of the required Sections of the application must include participation by a private sector for-profit or not-for-profit company that will be expected to contribute in a positive and significant way to the overall scientific agenda of the SRATP.

Wide-open applicant board · 15 Grants.gov doors

Sustained Release for Antiretroviral Treatmen… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Health · Income Security and Social Services (HL;ISS). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Sustained Release for Antiretroviral Treatmen… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.242;93.855;93.856;93.865 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants